Two European screeners.
Different tools for different investors.

Coverage — especially below large cap

Stockopedia covers global markets, but the product's editorial voice and screener quality are strongest in UK equities. For European investors screening Spanish, Italian, or German small caps, coverage gaps are real and documented by users in their forums.

ScreenerHero covers all active instruments on BME, Euronext Paris, XETRA, and Borsa Italiana — including microcaps. Coverage gaps in fundamentals data (common for illiquid names) are shown inline in the screener, not hidden.

Screener workflow — raw data vs scored ranks

Stockopedia's main innovation is the StockRanks system: a composite percentile that tells you how a stock ranks on quality, value, and momentum relative to its universe. It's well-designed and useful if you trust the methodology and want a shortcut.

ScreenerHero doesn't have a composite score. The screener exposes raw metrics — P/E, P/B, ROE, EV/EBITDA, profit margin, beta, dividend yield, and momentum — and lets you filter and sort by any combination. If your strategy has specific thresholds, this is faster. If you prefer a guided score, Stockopedia is the better fit.

Price — €60/mo vs €0 to start

Stockopedia starts at approximately €55–65/mo depending on your region and plan. There is no meaningful free tier — the trial is time-limited and gates most screener features.

ScreenerHero's core screener is free — no account, no trial period. Premium adds alerts, exports, and extended data at €25/mo. You can run a full session, build filter presets, and evaluate the data quality before paying anything.

UI philosophy — dense data vs narrative context

Stockopedia wraps its data in editorial commentary, company narratives, and a card-based layout. This works well for investors who want context and explanation alongside the numbers.

ScreenerHero is built desktop-first for analysis sessions of 30–90 minutes. The interface is dense, data-first, and optimised for speed — not for reading stories about a company. If you already know what you're looking for and want to filter a 1,000+ stock universe fast, that design difference matters.

Does ScreenerHero replace Stockopedia for the StockRanks methodology?

No. If StockRanks is your primary signal, ScreenerHero won't replicate it — there is no composite score. ScreenerHero is built for investors with their own criteria who want to apply those criteria to a clean dataset.

How does ScreenerHero handle the European coverage Stockopedia sometimes misses?

ScreenerHero is built exclusively for European equities. All active instruments from BME, Euronext Paris, XETRA, and Borsa Italiana are in the universe, including illiquid names. Where fundamental data is missing (more common in microcaps), the screener marks it explicitly.

Can I try ScreenerHero before committing?

Yes — the screener is open without login. Run your filters, check the coverage on the names you follow, and decide. No trial period, no time limit on the free tier.